January 13 2017. A study reported on December 23, 2016 in Biology Open suggests a benefit for niacin (vitamin B3) in the treatment of early stage Parkinson’s disease. The research involved fruit flies with a mutation which results in a condition similar to human Parkinson’s disease. L. Miguel Martins and colleagues at the University of Leicester fed the flies a diet supplemented with niacin, which is a precursor to nicotinamide adenine dinucleotide (NAD), a coenzyme needed for the generation of energy in the cells’ mitochondria. NAD also helps protect neurons from degeneration.
Patrice Wendling, April 15, 2016
Citing a lack of cardiovascular benefit, the FDA is taking the unusual step of withdrawing approvals it had previously given for use of niacin and fenofibric acid with statins to treat high cholesterol